Note 14 - Goodwill and Intangible Assets, Net (Tables)
|
3 Months Ended |
12 Months Ended |
Mar. 31, 2024 |
Dec. 31, 2023 |
| Notes Tables |
|
|
| Schedule of Goodwill Reportable Segments [Table Text Block] |
|
| |
|
e-Commerce Operations |
|
|
Healthcare Operations |
|
|
Total |
|
| Balances as of December 31, 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
| Goodwill |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
| Accumulated impairment losses |
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Goodwill, net as of December 31, 2021 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Changes in Goodwill during the year ended December 31, 2022: |
|
|
|
|
|
|
|
|
|
|
|
|
| Goodwill acquired |
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Impairment losses |
|
|
— |
|
|
|
— |
|
|
|
— |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Balances as of December 31, 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
| Goodwill |
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Accumulated impairment losses |
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Goodwill, net as of December 31, 2022 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Changes in Goodwill during the year ended December 31, 2023: |
|
|
|
|
|
|
|
|
|
|
|
|
| Goodwill acquired |
|
|
— |
|
|
|
14,626 |
|
|
|
14,626 |
|
| Impairment losses |
|
|
— |
|
|
|
(13,895 |
) |
|
|
(13,895 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Balances as of December 31, 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
| Goodwill |
|
|
— |
|
|
|
14,626 |
|
|
|
14,626 |
|
| Accumulated impairment losses |
|
|
— |
|
|
|
(13,895 |
) |
|
|
(13,895 |
) |
| Goodwill, net as of December 31, 2023 |
|
$ |
— |
|
|
$ |
731 |
|
|
$ |
731 |
|
|
| Schedule of Finite-Lived Intangible Assets [Table Text Block] |
| |
|
March 31, 2024 |
|
| |
|
(Unaudited) |
|
| |
|
Gross amount |
|
|
Accumulated amortization |
|
|
Net Amount |
|
| Pharmacy records |
|
$ |
8,130 |
|
|
$ |
(1,219 |
) |
|
$ |
6,911 |
|
| Trade names |
|
|
4,700 |
|
|
|
(353 |
) |
|
|
4,347 |
|
| Developed technology |
|
|
2,880 |
|
|
|
(432 |
) |
|
|
2,448 |
|
| Customer Contracts |
|
|
250 |
|
|
|
(231 |
) |
|
|
19 |
|
| Total intangible assets |
|
$ |
15,960 |
|
|
$ |
(2,235 |
) |
|
$ |
13,725 |
|
| |
|
December 31, 2023 |
|
| |
|
(Audited) |
|
| |
|
Gross amount |
|
|
Accumulated amortization |
|
|
Net Amount |
|
| Pharmacy records |
|
$ |
8,130 |
|
|
$ |
(807 |
) |
|
$ |
7,323 |
|
| Trade names |
|
|
4,700 |
|
|
|
(224 |
) |
|
|
4,476 |
|
| Developed technology |
|
|
2,880 |
|
|
|
(281 |
) |
|
|
2,599 |
|
| Customer Contracts |
|
|
250 |
|
|
|
(225 |
) |
|
|
25 |
|
| Total intangible assets |
|
$ |
15,960 |
|
|
$ |
(1,537 |
) |
|
$ |
14,423 |
|
|
| |
|
December 31, 2023 |
|
| |
|
Gross amount |
|
|
Accumulated amortization |
|
|
Net Amount |
|
| Pharmacy records |
|
$ |
8,130 |
|
|
$ |
(807 |
) |
|
$ |
7,323 |
|
| Trade names |
|
|
4,700 |
|
|
|
(224 |
) |
|
|
4,476 |
|
| Developed technology |
|
|
2,880 |
|
|
|
(281 |
) |
|
|
2,599 |
|
| Customer Contracts |
|
|
250 |
|
|
|
(225 |
) |
|
|
25 |
|
| Total intangible assets |
|
$ |
15,960 |
|
|
$ |
(1,537 |
) |
|
$ |
14,423 |
|
| |
|
December 31, 2022 |
|
| |
|
Gross amount |
|
|
Accumulated amortization |
|
|
Net Amount |
|
| Pharmacy records |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
| Trade names |
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Developed technology |
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Customer Contracts |
|
|
250 |
|
|
|
(200 |
) |
|
|
50 |
|
| Total intangible assets |
|
$ |
250 |
|
|
$ |
(200 |
) |
|
$ |
50 |
|
|
| Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] |
| Year |
|
|
Amount |
|
| 2024 (remaining nine months) |
|
$ |
2,023 |
|
| 2025 |
|
|
2,672 |
|
| 2026 |
|
|
2,672 |
|
| 2027 |
|
|
2,672 |
|
| 2028 |
|
|
1,571 |
|
| Thereafter |
|
|
2,115 |
|
| Total |
|
$ |
13,725 |
|
|
| |
|
|
Amount |
|
| 2024 |
|
$ |
2,721 |
|
| 2025 |
|
|
2,672 |
|
| 2026 |
|
|
2,672 |
|
| 2027 |
|
|
2,672 |
|
| 2028 |
|
|
1,571 |
|
| Thereafter |
|
|
2,115 |
|
| Total |
|
$ |
14,423 |
|
|